Sage Therapeutics CEO cashes in $35M worth of stock options
December 28, 2017 at 11:44 AM EST
Jeff Jonas, the CEO of a Cambridge developer of drugs to treat depression, got a holiday gift of more than $35 million last week after exercising stock options and then selling most of the resulting shares at record-high prices.
